A Real-World Registry Study of the Fluocinolone Acetonide Intravitreal Implant 0.18 Mg in Chronic Noninfectious Posterior Uveitis
Latest Information Update: 13 Oct 2023
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Posterior uveitis
- Focus Adverse reactions; Therapeutic Use
- Acronyms CALM
- Sponsors EyePoint Pharmaceuticals
- 11 Oct 2023 According to an Alimera Sciences Media Release, data from this study will be presented during the Retina Societys 56th Annual Scientific Meeting being held in New York City.
- 02 Mar 2023 According to an EyePoint Pharmaceuticals media release, data from this study was presented at the Retina Society 55th Annual Scientific Meeting in November 2022.
- 02 Mar 2023 According to an EyePoint Pharmaceuticals media release, data of this study will be presented at the 2023 ARVO Annual Meeting in April.